Full title: A Phase 1 Study of INBRX-109 in Subjects with Locally Advanced or Metastatic Solid Tumours Including Sarcomas
Age: 12-85
Phase: 1
Locations:
- London – Great North’s Children’s Hospital, University College London Hospital, The Royal Marsden NHS Trust
- Manchester – Royal Manchester Children’s Hospital
Brief summary:
This study is a phase 1 trial looking at the drug INBRX-109. Researchers want to understand its safety and side effects in people with Ewing sarcoma. It is open to patients whose sarcoma has not responded to standard treatments.
More information can be found at clinicaltrials.gov
To find out more about this trial and whether you could take part, talk to your clinical team.
